Chiba Shumpei, Itoga Takaaki, Asada Kazuo, Yabe Daisuke
EY Strategy and Consulting Co., Ltd., Tokyo, Japan.
Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
J Diabetes Investig. 2025 Jun;16(6):1091-1099. doi: 10.1111/jdi.70035. Epub 2025 Apr 2.
AIMS/INTRODUCTION: This study aimed to improve efficiency of participant selection in Japan's Specific Health Guidance (SHG) program by developing a model to predict 3-year risk of diabetes complications. The targeted complications included macrovascular diseases (ischemic heart disease and cerebrovascular disease), microvascular diseases (diabetic nephropathy, diabetic neuropathy, diabetic retinopathy), and chronic kidney disease (CKD).
We utilized the Kokuho Database to analyze individuals in Saga Prefecture who underwent Specific Health Checkups from 2016 to 2019 without diabetes complications at baseline. To evaluate risk of the complications across all examinees, we excluded medicated individuals ineligible for SHG, while including those without diabetes in the prediction cohort. The outcomes of diabetes complications were derived from claims data. Explanatory variables included health checkup results, questionnaire responses, medical diagnoses, and prescription records. The predictive model was constructed using logistic regression, and its performance was evaluated using the Area Under the Curve (AUC) from fivefold cross-validation.
Through model optimization techniques, including stratification, the incorporation of quadratic terms, and variable selection, the AUC exceeded 0.7 for all conditions. Notably, the AUC for microvascular complications and CKD surpassed 0.8, indicating high predictive accuracy. The model identified a higher risk among individuals who met the health guidance criteria established by the Ministry of Health, Labour and Welfare, demonstrating alignment with existing standards.
This predictive model has potential to enhance the targeting process for health guidance in Japan, enabling more timely medical intervention. Its implementation could significantly contribute to the prevention of severe diabetes complications through earlier detection and treatment.
目的/引言:本研究旨在通过开发一个预测糖尿病并发症3年风险的模型,提高日本特定健康指导(SHG)项目中参与者选择的效率。目标并发症包括大血管疾病(缺血性心脏病和脑血管疾病)、微血管疾病(糖尿病肾病、糖尿病神经病变、糖尿病视网膜病变)和慢性肾脏病(CKD)。
我们利用国保数据库分析了2016年至2019年在佐贺县接受特定健康检查且基线时无糖尿病并发症的个体。为了评估所有受检者发生并发症的风险,我们排除了不符合SHG资格的用药个体,同时将无糖尿病的个体纳入预测队列。糖尿病并发症的结果来自理赔数据。解释变量包括健康检查结果、问卷回答、医学诊断和处方记录。使用逻辑回归构建预测模型,并通过五重交叉验证的曲线下面积(AUC)评估其性能。
通过包括分层、纳入二次项和变量选择在内的模型优化技术,所有情况的AUC均超过0.7。值得注意的是,微血管并发症和CKD的AUC超过0.8,表明预测准确性高。该模型在符合厚生劳动省制定的健康指导标准的个体中识别出更高的风险,表明与现有标准一致。
这种预测模型有可能加强日本健康指导的目标设定过程,实现更及时的医疗干预。其实施可通过早期检测和治疗,对预防严重糖尿病并发症做出重大贡献。